Movement Alert｜3SBio Rises 5.04% in Regular Trading, Biotech Sector Collective Rebound Combined with Continuous Institutional Accumulation

Market Focus06-18

On June 18, 3SBio rose 5.04% in regular trading, trading at HK$16.83/share, with turnover of HK$159 million. The rally was driven by a broad-based rebound in the biotechnology sector alongside sustained institutional and management buying.

On the sector front, biotech stocks staged a notable recovery following a collective selloff on June 16. Akeso gained 6.08%, Remegen rose 4.90%, SKB Bio climbed 4.91%, BeiGene advanced 4.51%, and Innovent Bio added 3.67%, indicating a clear sector-wide rebound pattern.

On the capital flow side, Fullgoal Fund Management increased its stake in 3SBio by 636,500 shares on June 10 at an average price of HK$16.28, bringing its total holding to approximately 177.76 million shares or 7.00% of issued capital. Prior to that, Fullgoal had also purchased 975,000 shares on June 5. Additionally, company Chairman Lou Jing acquired 516,000 shares on June 8 at HK$15.25 per share. The consecutive buying from both institutional investors and senior management has provided meaningful support to market confidence.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147911226?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 10:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147911226","market":"us","top_or_hot":-1,"title":"Movement Alert｜3SBio Rises 5.04% in Regular Trading, Biotech Sector Collective Rebound Combined with Continuous Institutional Accumulation","media":"Market Focus","content":"<p><p>On June 18, 3SBio rose 5.04% in regular trading, trading at HK$16.83/share, with turnover of HK$159 million. The rally was driven by a broad-based rebound in the biotechnology sector alongside sustained institutional and management buying.</p><p>On the sector front, biotech stocks staged a notable recovery following a collective selloff on June 16. Akeso gained 6.08%, Remegen rose 4.90%, SKB Bio climbed 4.91%, BeiGene advanced 4.51%, and Innovent Bio added 3.67%, indicating a clear sector-wide rebound pattern.</p><p>On the capital flow side, Fullgoal Fund Management increased its stake in 3SBio by 636,500 shares on June 10 at an average price of HK$16.28, bringing its total holding to approximately 177.76 million shares or 7.00% of issued capital. Prior to that, Fullgoal had also purchased 975,000 shares on June 5. Additionally, company Chairman Lou Jing acquired 516,000 shares on June 8 at HK$15.25 per share. The consecutive buying from both institutional investors and senior management has provided meaningful support to market confidence.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜3SBio Rises 5.04% in Regular Trading, Biotech Sector Collective Rebound Combined with Continuous Institutional Accumulation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜3SBio Rises 5.04% in Regular Trading, Biotech Sector Collective Rebound Combined with Continuous Institutional Accumulation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-18 10:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 18, 3SBio rose 5.04% in regular trading, trading at HK$16.83/share, with turnover of HK$159 million. The rally was driven by a broad-based rebound in the biotechnology sector alongside sustained institutional and management buying.</p><p>On the sector front, biotech stocks staged a notable recovery following a collective selloff on June 16. Akeso gained 6.08%, Remegen rose 4.90%, SKB Bio climbed 4.91%, BeiGene advanced 4.51%, and Innovent Bio added 3.67%, indicating a clear sector-wide rebound pattern.</p><p>On the capital flow side, Fullgoal Fund Management increased its stake in 3SBio by 636,500 shares on June 10 at an average price of HK$16.28, bringing its total holding to approximately 177.76 million shares or 7.00% of issued capital. Prior to that, Fullgoal had also purchased 975,000 shares on June 5. Additionally, company Chairman Lou Jing acquired 516,000 shares on June 8 at HK$15.25 per share. The consecutive buying from both institutional investors and senior management has provided meaningful support to market confidence.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"","article_id":"1147911226","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147911226","pubTimestamp":1781749717,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 18, 3SBio rose 5.04% in regular trading, trading at HK$16.83/share, with turnover of HK$159 million. The rally was driven by a broad-based rebound in the biotechnology sector alongside...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01530":"三生制药"},"translate_title":"异动快讯|三生制药常规盘涨5.04%生物科技板块集体反弹叠加机构持续加仓","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1},"content_text":"On June 18, 3SBio rose 5.04% in regular trading, trading at HK$16.83/share, with turnover of HK$159 million. The rally was driven by a broad-based rebound in the biotechnology sector alongside sustained institutional and management buying.On the sector front, biotech stocks staged a notable recovery following a collective selloff on June 16. Akeso gained 6.08%, Remegen rose 4.90%, SKB Bio climbed 4.91%, BeiGene advanced 4.51%, and Innovent Bio added 3.67%, indicating a clear sector-wide rebound pattern.On the capital flow side, Fullgoal Fund Management increased its stake in 3SBio by 636,500 shares on June 10 at an average price of HK$16.28, bringing its total holding to approximately 177.76 million shares or 7.00% of issued capital. Prior to that, Fullgoal had also purchased 975,000 shares on June 5. Additionally, company Chairman Lou Jing acquired 516,000 shares on June 8 at HK$15.25 per share. The consecutive buying from both institutional investors and senior management has provided meaningful support to market confidence.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147911226","isCrawlerRequest":true}